<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url><loc>https://www.amoon.fund/</loc></url>
<url><loc>https://www.amoon.fund/12-על-12-הדמויות-המשפיעות-בענף-ההלתטק/</loc></url>
<url><loc>https://www.amoon.fund/2022-top-10-innovations/</loc></url>
<url><loc>https://www.amoon.fund/2023-europe-health-tech-200-holoniqs-annual-list-of-the-200-most-promising-health-tech-startups-from-europe/</loc></url>
<url><loc>https://www.amoon.fund/2023-fierce-life-sciences-innovation-awards-winners/</loc></url>
<url><loc>https://www.amoon.fund/30-דקות-או-פחות-הטכנולוגיה-נכנסה-לתוך-הב/</loc></url>
<url><loc>https://www.amoon.fund/5-minutes-with-abigail-hirsch-co-founder-of-lin-health/</loc></url>
<url><loc>https://www.amoon.fund/a-healthcare-investment-fund-has-become-one-of-israels-largest-with-a-660-million-close/</loc></url>
<url><loc>https://www.amoon.fund/a-new-test-could-save-arthritis-patients-time-money-and-pain-but-will-it-be-used/</loc></url>
<url><loc>https://www.amoon.fund/additional-strategic-funding-for-cartiheals-ongoing-agili-c-ide-clinical-study/</loc></url>
<url><loc>https://www.amoon.fund/adicet-announces-completion-of-merger-with-restorbio/</loc></url>
<url><loc>https://www.amoon.fund/adicet-unveils-early-responses-for-off-the-shelf-drug-leveraging-rare-t-cells-will-durability-hold-up/</loc></url>
<url><loc>https://www.amoon.fund/ai-for-population-health-and-medical-imaging-gets-a-boost-with-230-million-acquisitions/</loc></url>
<url><loc>https://www.amoon.fund/ai-in-healthcare-award-for-nhs-deployment-of-ibexs-galen-breast/</loc></url>
<url><loc>https://www.amoon.fund/ai-triage-solution-for-brain-bleeds-gains-fda-clearance/</loc></url>
<url><loc>https://www.amoon.fund/alexa-do-i-have-covid-19/</loc></url>
<url><loc>https://www.amoon.fund/alpha/</loc></url>
<url><loc>https://www.amoon.fund/amazon-health-launches-new-initiative-to-address-chronic-conditions/</loc></url>
<url><loc>https://www.amoon.fund/amoon-invests-in-80m-adicet-bio-financing-round/</loc></url>
<url><loc>https://www.amoon.fund/amoon-un-pri-announcement/</loc></url>
<url><loc>https://www.amoon.fund/amoons-healthtech-roundup-q2-2023/</loc></url>
<url><loc>https://www.amoon.fund/an-israeli-biotech-is-looking-to-make-its-name-in-the-jam-packed-cd47-space-is-bifunctionality-the-answer/</loc></url>
<url><loc>https://www.amoon.fund/andreessen-founders-fund-back-genomics-startup-exiting-stealth/</loc></url>
<url><loc>https://www.amoon.fund/apparently-getting-smarter-makes-us-healthier-ai-and-data-analysis-revolutionize-healthcare/</loc></url>
<url><loc>https://www.amoon.fund/are-devices-the-next-gen-pharmaceuticals/</loc></url>
<url><loc>https://www.amoon.fund/ayala-notches-up-17m-in-financing-to-push-bms-drug-into-phase-2/</loc></url>
<url><loc>https://www.amoon.fund/ayala-pharmaceuticals-announces-closing-of-merger-with-biosight/</loc></url>
<url><loc>https://www.amoon.fund/ayala-pharmaceuticals-announces-pricing-of-initial-public-offering/</loc></url>
<url><loc>https://www.amoon.fund/ayala-pharmaceuticals-founded-by-israel-biotech-fund-amoon-and-harel-insurance-enters-exclusive-worldwide-license-agreement-with-bristol-myers-squibb-bms-to-develop-cancer-treatments/</loc></url>
<url><loc>https://www.amoon.fund/ayala-pharmaceuticals-raises-30-million/</loc></url>
<url><loc>https://www.amoon.fund/ayala-pharmaceuticals-to-present-preclinical-data-at-aacr-for-al101-a-pan-notch-inhibitor-being-evaluated-for-adenoid-cystic-carcinoma/</loc></url>
<url><loc>https://www.amoon.fund/biondvax-niaid-kick-off-phase-2-universal-flu-vaccine-study-in-u-s/</loc></url>
<url><loc>https://www.amoon.fund/can-start-ups-significantly-lower-the-cost-of-gene-sequencing/</loc></url>
<url><loc>https://www.amoon.fund/careers/</loc></url>
<url><loc>https://www.amoon.fund/cartiheal-enrolls-the-200th-patient-in-its-pivotal-clinical-study-in-san-diego-ca/</loc></url>
<url><loc>https://www.amoon.fund/cartiheal-raises-18-3m-to-support-pma-trial-of-agili-c-implant/</loc></url>
<url><loc>https://www.amoon.fund/combining-machine-learning-tools-for-medical-imaging-with-genetic-sequencing-nets-sophia-genetics-110m/</loc></url>
<url><loc>https://www.amoon.fund/computational-pathology-pioneer-ibex-raises-11m/</loc></url>
<url><loc>https://www.amoon.fund/covid-put-everything-on-steroids-says-prominent-healthtech-investor/</loc></url>
<url><loc>https://www.amoon.fund/curesponse-secures-6m-series-a-for-breakthrough-precision-medicine/</loc></url>
<url><loc>https://www.amoon.fund/dia-eats-world-how-enabling-technologies-revolutionize-care/</loc></url>
<url><loc>https://www.amoon.fund/diets-engineered-to-work-with-your-microbiome-are-latest-startup-craze/</loc></url>
<url><loc>https://www.amoon.fund/driving-to-target-how-adicet-bios-novel-therapy-addresses-key-drawbacks-in-immune-oncology/</loc></url>
<url><loc>https://www.amoon.fund/eleos-health-raises-20-million-to-generate-insights-from-mental-health-clinician-patient-conversations/</loc></url>
<url><loc>https://www.amoon.fund/eleos-health-raises-8m-for-behavioral-health-focused-ai-voice-tech/</loc></url>
<url><loc>https://www.amoon.fund/eli-lilly-adds-a-15m-equity-sweetener-for-its-platform-partner-in-sarna/</loc></url>
<url><loc>https://www.amoon.fund/exclusive-eleos-health-banks-40m-series-b-to-quantify-therapy-with-voice/</loc></url>
<url><loc>https://www.amoon.fund/fda-grants-theranica-de-novo-to-market-first-smartphone-controlled-acute-migraine-relief-wearable-device/</loc></url>
<url><loc>https://www.amoon.fund/first-participant-enrolled-in-second-cohort-of-biondvaxs-pivotal-clinical-efficacy-phase-3-universal-flu-vaccine-trial/</loc></url>
<url><loc>https://www.amoon.fund/from-post-it-notes-to-ai-how-ai-technology-can-improve-workflow-for-mental-health-clinicians/</loc></url>
<url><loc>https://www.amoon.fund/gains-in-trnaslation-its-time-for-investors-to-realize-the-potential-of-european-rna-technologies/</loc></url>
<url><loc>https://www.amoon.fund/global-spend-on-healthcare-is-by-and-large-recession-proof/</loc></url>
<url><loc>https://www.amoon.fund/growth/</loc></url>
<url><loc>https://www.amoon.fund/guardant-buys-metasight-for-59m-upfront-to-acquire-blood-test-tech/</loc></url>
<url><loc>https://www.amoon.fund/healthcare-is-going-vocal/</loc></url>
<url><loc>https://www.amoon.fund/herd-immunity-or-big-2nd-wave-israel-antibody-testing-hopes-to-find-out/</loc></url>
<url><loc>https://www.amoon.fund/here-are-six-major-breakthroughs-achieved-by-bay-area-women-led-biotechs/</loc></url>
<url><loc>https://www.amoon.fund/higher-bills-are-leading-americans-to-delay-medical-care/</loc></url>
<url><loc>https://www.amoon.fund/how-ai-interfaces-can-help-therapists-provide-better-behavioral-health-care/</loc></url>
<url><loc>https://www.amoon.fund/how-ai-interfaces-can-help-therapists-provide-better-behavioral-healthcare/</loc></url>
<url><loc>https://www.amoon.fund/ibex-inks-deal-with-astrazeneca-daiichi-sankyo-to-develop-ai-based-her2-scoring/</loc></url>
<url><loc>https://www.amoon.fund/ibex-launches-galen-breast-her2-supporting-improved-biomarker-scoring-in-breast-cancer-patients/</loc></url>
<url><loc>https://www.amoon.fund/ibex-medical-analytics-granted-breakthrough-device-designation-by-the-fda-fast-tracking-its-approval/</loc></url>
<url><loc>https://www.amoon.fund/ibex-medical-analytics-raises-38m-for-its-ai-powered-cancer-diagnostic-platform/</loc></url>
<url><loc>https://www.amoon.fund/ibex-medical-raises-55-million-series-c-for-ai-powered-cancer-diagnostics/</loc></url>
<url><loc>https://www.amoon.fund/ibex-obtains-ce-ivd-mark-for-ai-powered-cancer-detection/</loc></url>
<url><loc>https://www.amoon.fund/insight/</loc></url>
<url><loc>https://www.amoon.fund/interview-healthtech-is-israels-next-growth-engine-says-venture-capitalist/</loc></url>
<url><loc>https://www.amoon.fund/investors-expect-to-pour-more-funds-into-digital-health-survey-shows/</loc></url>
<url><loc>https://www.amoon.fund/is-weight-loss-the-ultimate-solution-for-all-our-health-problems/</loc></url>
<url><loc>https://www.amoon.fund/israel-based-healthcare-investor-amoon-expands-to-boston-is-raising-growth-fund/</loc></url>
<url><loc>https://www.amoon.fund/israel-bolsters-antibody-tests-as-second-virus-wave-threatens/</loc></url>
<url><loc>https://www.amoon.fund/israeli-firm-creates-particles-to-kill-germs-on-contact-fight-bacterial-disease/</loc></url>
<url><loc>https://www.amoon.fund/israeli-health-fund-amoon-ii-raises-660-million/</loc></url>
<url><loc>https://www.amoon.fund/israeli-healthtech-startups-raised-2-8-billion-in-2022-but-tech-crisis-threatens-growth/</loc></url>
<url><loc>https://www.amoon.fund/israeli-healthtech-vc-amoon-velocity-invests-6-million-in-nectin-therapeutics/</loc></url>
<url><loc>https://www.amoon.fund/israeli-healthtech-venture-fund-sees-industry-revolution/</loc></url>
<url><loc>https://www.amoon.fund/israeli-migraine-device-co-theranica-raises-35m/</loc></url>
<url><loc>https://www.amoon.fund/israels-10-hottest-startups-in-2019-according-to-wired-magazine/</loc></url>
<url><loc>https://www.amoon.fund/israels-largest-health-vc-boosts-fund-to-750-million-on-virus/</loc></url>
<url><loc>https://www.amoon.fund/israels-zebra-medical-gets-fda-ok-for-ai-chest-x-ray-product/</loc></url>
<url><loc>https://www.amoon.fund/kahr-announces-46-5-million-financing-to-advance-its-multifunctional-immunotherapeutic-pipeline/</loc></url>
<url><loc>https://www.amoon.fund/karius-raises-165-million-for-its-liquid-biopsy-technology-identifying-diseases-with-a-blood-draw/</loc></url>
<url><loc>https://www.amoon.fund/leveraging-leap-to-form-the-next-wave-of-healthtech-startups/</loc></url>
<url><loc>https://www.amoon.fund/life-sciences-vc-amoon-raises-340-million-for-second-fund/</loc></url>
<url><loc>https://www.amoon.fund/life-sciences-venture-fund-amoon-invests-5-million-in-cancer-drug-company/</loc></url>
<url><loc>https://www.amoon.fund/lilly-enlists-a-long-incubating-rna-upstart-in-new-1-25b-partnership/</loc></url>
<url><loc>https://www.amoon.fund/mapi-pharma-ltd-announces-closing-of-10-million-investment/</loc></url>
<url><loc>https://www.amoon.fund/mapping-mental-health-innovation-in-israel/</loc></url>
<url><loc>https://www.amoon.fund/marius-nacht-buys-controlling-stake-in-universal-flu-vaccine-developer-biondvax/</loc></url>
<url><loc>https://www.amoon.fund/marius-nacht-to-invest-20m-in-regenera/</loc></url>
<url><loc>https://www.amoon.fund/marius-nacht/</loc></url>
<url><loc>https://www.amoon.fund/mdclone-awarded-as-technology-pioneer-by-world-economic-forum/</loc></url>
<url><loc>https://www.amoon.fund/mdclone-developer-of-first-healthcare-synthetic-data-engine-raises-26-million/</loc></url>
<url><loc>https://www.amoon.fund/medial-earlysigns-clinical-validation-trial-shows-promise-for-detecting-colorectal-cancer/</loc></url>
<url><loc>https://www.amoon.fund/meet-the-israeli-startups-joining-googles-growth-lab/</loc></url>
<url><loc>https://www.amoon.fund/metasight-diagnostics-emerges-from-stealth-and-announces-partnership-with-maccabis-ksm-research-and-innovation-center-to-conduct-extensive-metabolomics-research/</loc></url>
<url><loc>https://www.amoon.fund/michael-ehlers-is-betting-40m-that-an-ai-outfit-has-figured-out-how-to-beat-the-blockbuster-il-2-challenge/</loc></url>
<url><loc>https://www.amoon.fund/mina-therapeutics-secures-23-million-series-a-financing-to-advance-first-in-class-activating-rna-based-therapeutics/</loc></url>
<url><loc>https://www.amoon.fund/mobilion-closes-35m-series-b-financing-round/</loc></url>
<url><loc>https://www.amoon.fund/mobilion-systems-racks-up-another-60m-to-bring-faster-smarter-mass-spectrometry-to-biopharma/</loc></url>
<url><loc>https://www.amoon.fund/myeloma-investment-fund-invests-in-nectin-therapeutics-to-evaluate-nectins-anti-pvr-lead-drug-candidate-as-a-treatment-for-multiple-myeloma/</loc></url>
<url><loc>https://www.amoon.fund/nacht-harel-insurance-invest-in-personalized-cancer-treatment/</loc></url>
<url><loc>https://www.amoon.fund/nectin-therapeutics-announces-5-4-million-investment-from-cancer-focus-fund-to-support-phase-1-study-of-first-in-class-anti-pvr-targeted-immunotherapy/</loc></url>
<url><loc>https://www.amoon.fund/nectin-therapeutics-merck-team-up-on-immunotherapy-combo-trial-in-solid-cancers/</loc></url>
<url><loc>https://www.amoon.fund/nectin-therapeutics-raises-25-million-series-a-to-treat-advanced-cancer-tumors/</loc></url>
<url><loc>https://www.amoon.fund/new-i-o-targets-herald-a-decade-of-drugging-the-undruggable/</loc></url>
<url><loc>https://www.amoon.fund/new-name-new-board-new-focus-altrubio-relaunches-with-63m-series-a/</loc></url>
<url><loc>https://www.amoon.fund/new-obesity-drugs-are-in-the-works-trying-to-out-blockbuster-wegovy-and-mounjaro/</loc></url>
<url><loc>https://www.amoon.fund/newly-merged-voice-analysis-startups-healthymize-and-beyond-verbal-raise-9-million/</loc></url>
<url><loc>https://www.amoon.fund/news/</loc></url>
<url><loc>https://www.amoon.fund/news/page/2/</loc></url>
<url><loc>https://www.amoon.fund/news/page/3/</loc></url>
<url><loc>https://www.amoon.fund/news/page/4/</loc></url>
<url><loc>https://www.amoon.fund/news/page/5/</loc></url>
<url><loc>https://www.amoon.fund/nih-partners-with-israeli-startup-to-generate-synthetic-covid-19-data/</loc></url>
<url><loc>https://www.amoon.fund/nobio-gets-fda-approval-for-anti-bacterial-dental-fillings/</loc></url>
<url><loc>https://www.amoon.fund/omada-glp-1-program-to-prioritize-muscle-mass-restoration-through-expanded-care-track/</loc></url>
<url><loc>https://www.amoon.fund/omada-health-valued-at-1-billion-plus-in-fidelity-led-round/</loc></url>
<url><loc>https://www.amoon.fund/paving-the-way-for-targeted-medicine-what-does-the-future-hold-for-tools-diagnostics/</loc></url>
<url><loc>https://www.amoon.fund/pharma-two-b-doses-first-patients-in-early-stage-parkinsons-phase-3-trial/</loc></url>
<url><loc>https://www.amoon.fund/pharma-two-b-ltd-closes-30-million-financing-round/</loc></url>
<url><loc>https://www.amoon.fund/platform-to-pipeline-transformation/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/149-2/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/adcytherix/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/adicet/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/air-doctor/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/akoya-biosciences/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/altrubio-logo-needed/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/ayala-pharmaceuticals/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/better-life-partners/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/biolojic-design/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/biosplice-therapeutics/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/breeoot-clinic/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/cartiheal/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/cavos/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/character-bio/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/coltac-therapeutics/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/connie-health/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/eleos/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/graphiterx/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/hopscotch-primary-care/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/iantrek/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/ibex/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/kahr/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/lin-health/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/lutris-pharma/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/lyfegen/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/mdclone/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/metasight/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/mina-therapeutics/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/mobilion-systems-inc/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/nanoghost/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/nectin-therapeutics/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/omada/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/pacegenix/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/plexium/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/positive-development/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/prognomiq/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/satellite-biosciences/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/scipher-medicine/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/seer/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/sera-prognostics/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/stealth/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/theranica/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/viracta/</loc></url>
<url><loc>https://www.amoon.fund/portfolio/zebra-medical-vision/</loc></url>
<url><loc>https://www.amoon.fund/precision-immunology-player-bags-110m-to-fund-its-work-on-disease-signature-tests/</loc></url>
<url><loc>https://www.amoon.fund/privacy-policy/</loc></url>
<url><loc>https://www.amoon.fund/quest-diagnostics-and-ultima-collaborate-to-scale-ultimas-technology-in-fast-growing-minimal-residual-disease-and-whole-genome-sequencing/</loc></url>
<url><loc>https://www.amoon.fund/qumras-top-11-the-israeli-startups-to-watch-out-for-in-2024/</loc></url>
<url><loc>https://www.amoon.fund/remote-electric-neuromodulation-device-approval-extended-to-treatment-of-chronic-migraine/</loc></url>
<url><loc>https://www.amoon.fund/rising-amoon-and-its-growing-portfolio-at-the-healthcare-tech-interface/</loc></url>
<url><loc>https://www.amoon.fund/roche-collaborates-with-ibex-and-amazon-web-services-to-accelerate-adoption-of-ai-enabled-digital-pathology-solutions-to-help-improve-cancer-diagnoses/</loc></url>
<url><loc>https://www.amoon.fund/roche-invests-millions-in-israels-health-tech-sector/</loc></url>
<url><loc>https://www.amoon.fund/scipher-medicine-announces-82-million-financing/</loc></url>
<url><loc>https://www.amoon.fund/scipher-medicine-receives-medicare-coverage-for-prismra-test-in-rheumatoid-arthritis-patients/</loc></url>
<url><loc>https://www.amoon.fund/scipher-medicine-signs-multi-target-partnership-with-ionis/</loc></url>
<url><loc>https://www.amoon.fund/seer-announces-55-million-in-series-d-equity-financing-bringing-in-new-investors-amoon-fund-and-t-rowe-price-funds/</loc></url>
<url><loc>https://www.amoon.fund/seer-announces-spin-out-of-prognomiq-with-55-million-initial-financing/</loc></url>
<url><loc>https://www.amoon.fund/seizing-the-healthtech-opportunity-early-stage-innovation-takes-center-stage/</loc></url>
<url><loc>https://www.amoon.fund/sheba-medical-center-inaugurates-worlds-first-adams-center-with-mdclone-platform/</loc></url>
<url><loc>https://www.amoon.fund/small-activating-rnas-lead-the-charge-to-turn-up-gene-expression/</loc></url>
<url><loc>https://www.amoon.fund/sophia-genetics-expands-partnership-with-astrazeneca-to-include-multimodal-approaches-for-cancer-drug-development/</loc></url>
<url><loc>https://www.amoon.fund/sophia-genetics-ge-healthcare-begin-deep-lung-iv-data-collection-technology-integration/</loc></url>
<url><loc>https://www.amoon.fund/sophia-genetics-memorial-sloan-kettering-astrazeneca-partner-to-broaden-cancer-sequencing-access/</loc></url>
<url><loc>https://www.amoon.fund/sophia-genetics-raises-234m-in-ipo-eyes-additional-partnerships/</loc></url>
<url><loc>https://www.amoon.fund/startups-take-on-illumina-in-race-for-cheaper-dna-sequencing/</loc></url>
<url><loc>https://www.amoon.fund/steven-mnuchin-israeli-health-officials-discuss-establishment-of-israeli-fda-branch/</loc></url>
<url><loc>https://www.amoon.fund/substance-use-treatment-startup-better-life-partners-completes-26-5m-series-b-fundraise/</loc></url>
<url><loc>https://www.amoon.fund/taking-the-temperature-asco-2024/</loc></url>
<url><loc>https://www.amoon.fund/team/</loc></url>
<url><loc>https://www.amoon.fund/team/Advisors/</loc></url>
<url><loc>https://www.amoon.fund/team/Advisors/david-j-shulkin-md/</loc></url>
<url><loc>https://www.amoon.fund/team/Advisors/isaac-devash/</loc></url>
<url><loc>https://www.amoon.fund/team/Advisors/lloyd-b-minor-md/</loc></url>
<url><loc>https://www.amoon.fund/team/Advisors/michael-sherman/</loc></url>
<url><loc>https://www.amoon.fund/team/Advisors/robert-langer/</loc></url>
<url><loc>https://www.amoon.fund/team/Advisors/samuel-moed/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/adam-kotzen/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/daniel-sass-md-mba/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/david-esra-md/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/hagai-marmor-kollet-phd/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/moshic-mor/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/patrick-rivers/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/reut-shema-phd/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/rey-mozer-md-mba/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/roy-wiesner/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/ryan-berry-phd/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/sharon-feldman-phd/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/todd-sone/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/tomer-berkovitz-phd/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/yair-schindel-md/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-investment-team/yaron-daniely-phd/</loc></url>
<url><loc>https://www.amoon.fund/team/amoon-velocity/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/bar-katzir/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/david-dubinsky/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/gaby-hirsch/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/irena-katsman/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/karin-zaum/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/keren-ditkovsky/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/maayan-janus/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/masha-sherman/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/natalie-chazon/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/nataly-lipovyak/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/noah-lasson/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/noam-waldoks/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/rebecca-peretz/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/reva-sanders/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/sarit-tannenbaum/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/sivan-moshe/</loc></url>
<url><loc>https://www.amoon.fund/team/platform/yodfat-melzer/</loc></url>
<url><loc>https://www.amoon.fund/team/tomer-berkovitz-phd/</loc></url>
<url><loc>https://www.amoon.fund/terms-of-service/</loc></url>
<url><loc>https://www.amoon.fund/teva-pharma-to-receive-exclusive-rights-to-develop-manufacture-and-commercialize-bd9/</loc></url>
<url><loc>https://www.amoon.fund/the-10-most-innovative-biotech-companies-of-2023/</loc></url>
<url><loc>https://www.amoon.fund/the-10-most-innovative-companies-in-data-science-of-2023/</loc></url>
<url><loc>https://www.amoon.fund/the-50-most-promising-israeli-startups-2023/</loc></url>
<url><loc>https://www.amoon.fund/the-6-next-big-things-in-healthtech-for-2023/</loc></url>
<url><loc>https://www.amoon.fund/the-endpoints-11-the-biotech-startups-making-the-biggest-bets-with-the-most-exciting-science-in-2023/</loc></url>
<url><loc>https://www.amoon.fund/the-marvelous-world-of-mrna-a-kariko-moment-of-pride/</loc></url>
<url><loc>https://www.amoon.fund/the-omics-era-dawns-for-tools-and-diagnostics/</loc></url>
<url><loc>https://www.amoon.fund/the-people-in-this-medical-research-are-fake-the-innovations-are-real/</loc></url>
<url><loc>https://www.amoon.fund/the-unholy-grail-with-the-divestment-of-grail-by-illumina-whats-in-store-for-the-future-of-dna-sequencing-and-liquid-bio/</loc></url>
<url><loc>https://www.amoon.fund/the-year-healthtech-grew-wings/</loc></url>
<url><loc>https://www.amoon.fund/theranica-partners-with-dr-reddys-for-marketing-wearable-nerivio-in-india/</loc></url>
<url><loc>https://www.amoon.fund/unlocking-asco-2023-amoons-key-takeaways/</loc></url>
<url><loc>https://www.amoon.fund/ushering-in-a-new-era-the-100-genome-is-here/</loc></url>
<url><loc>https://www.amoon.fund/velocity/</loc></url>
<url><loc>https://www.amoon.fund/venture-capitalists-find-more-to-israel-than-zionism/</loc></url>
<url><loc>https://www.amoon.fund/viracta-therapeutics-announces-closing-of-merger-with-sunesis-pharmaceuticals-and-65m-private-placement/</loc></url>
<url><loc>https://www.amoon.fund/warburg-pincus-co-leads-latest-funding-round-in-israels-mdclone/</loc></url>
<url><loc>https://www.amoon.fund/we-are-focusing-on-strengthening-our-leadership-muscle-amid-war-says-eleos-health/</loc></url>
<url><loc>https://www.amoon.fund/we-just-made-our-largest-investment-to-date-in-seer-let-us-tell-you-why/</loc></url>
<url><loc>https://www.amoon.fund/we_believe/</loc></url>
<url><loc>https://www.amoon.fund/welcome-to-tissue-therapeutics-dave-lennons-110m-new-venture-will-implant-happy-cells-that-survive-and-thrive/</loc></url>
<url><loc>https://www.amoon.fund/what-makes-an-ai-drug-discovery-engine-stand-out/</loc></url>
<url><loc>https://www.amoon.fund/what-we-look-for-in-companies/</loc></url>
<url><loc>https://www.amoon.fund/when-the-stars-align-the-story-of-our-investment-in-sophia-genetics/</loc></url>
<url><loc>https://www.amoon.fund/will-the-quickly-developed-vaccines-deliver-covid-19-a-knockout-blow/</loc></url>
<url><loc>https://www.amoon.fund/zebra-medical-vision-gets-30m-series-c-to-create-ai-based-tools-for-radiologists/</loc></url>
<url><loc>https://www.amoon.fund/zebra-medical-vision-secures-its-5th-fda-clearance-making-its-vertebral-compression-fractures-ai-solution-available-in-the-u-s/</loc></url>
<url><loc>https://www.amoon.fund/אחרי-המלחמה-נראה-פה-גל-של-יזמים-טכנולו/</loc></url>
<url><loc>https://www.amoon.fund/אל-תנהגו-בפאניקה-ותרוצו-מיד-לפיטורים-ו/</loc></url>
<url><loc>https://www.amoon.fund/בינה-מלאכותית-לפתולוגים-אייבקס-מדיקל/</loc></url>
<url><loc>https://www.amoon.fund/ה-ai-זה-כמו-הענן-בעבר-פעם-כל-חברה-בתחום-נח/</loc></url>
<url><loc>https://www.amoon.fund/הולך-להישפך-הרבה-כסף-לתחום-הקרנות-המס/</loc></url>
<url><loc>https://www.amoon.fund/המכונה-הסודית-של-גלעד-אלמוגי-שמרצפת-גנ/</loc></url>
<url><loc>https://www.amoon.fund/משקיעות-בביומד-הפרויקטים-החדשים-של-team8-ו-a/</loc></url>
<url><loc>https://www.amoon.fund/על-קו-הזינוק-נבחרת-הסטארט-אפים-2022/</loc></url>
<url><loc>https://www.amoon.fund/פחות-סטארט־אפים-חדשים-ועוד-שלושה-סיפו/</loc></url>
</urlset>
